Medical Filtration Market by Material (Polyethersulfone; Polyvinylidenefluoride), Applications (Dialysis; Sterile Processing), Process Technology (Ultrafiltration; Microfiltration), Design/Process, End-Users & Region - Global Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNITS CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of key secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 List of key primary interview participants
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of interviews with experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 GROWTH FORECAST
• 2.4 DATA TRIANGULATION
• 2.5 FACTOR ANALYSIS
• 2.6 RESEARCH ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL FILTRATION MARKET
• 4.2 MEDICAL FILTRATION MARKET, BY MATERIAL
• 4.3 MEDICAL FILTRATION MARKET, BY APPLICATION
• 4.4 MEDICAL FILTRATION MARKET, BY END USER
• 4.5 MEDICAL FILTRATION MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing demand for advanced healthcare solutions
    • 5.2.1.2 Rising awareness of infection control
    • 5.2.1.3 Technological advancements
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High capital investments
    • 5.2.2.2 Stringent regulatory compliance
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing healthcare investments in emerging economies
    • 5.2.3.2 Adoption of single-use technologies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Speed and yield issues
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.4.2 QUALITY
  • 5.4.3 SERVICE
• 5.5 MACROECONOMIC OUTLOOK
  • 5.5.1 GDP TRENDS AND FORECASTS
• 5.6 IMPACT OF AI/GEN AI
• 5.7 VALUE CHAIN ANALYSIS
  • 5.7.1 RAW MATERIAL SUPPLIERS
  • 5.7.2 MANUFACTURERS
  • 5.7.3 DISTRIBUTORS
  • 5.7.4 END USERS
• 5.8 ECOSYSTEM ANALYSIS
• 5.9 CASE STUDY ANALYSIS
  • 5.9.1 VALIDATING PEGASUS PRIME VIRUS REMOVAL FILTERS WITH PREFILTERS
  • 5.9.2 ENHANCING DIALYSIS FILTRATION EFFICIENCY - FRESENIUS MEDICAL CARE
  • 5.9.3 BLOOD FILTRATION FOR SEPSIS TREATMENT - CYTOSORBENTS CORPORATION
• 5.10 TARIFF AND REGULATORY LANDSCAPE
  • 5.10.1 ENVIRONMENTAL REGULATIONS
  • 5.10.2 NORTH AMERICA
  • 5.10.3 ASIA PACIFIC
  • 5.10.4 EUROPE
  • 5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.11 TECHNOLOGY ANALYSIS
  • 5.11.1 KEY TECHNOLOGIES
    • 5.11.1.1 Microfiltration
    • 5.11.1.2 Ultrafiltration
    • 5.11.1.3 Nanofiltration
  • 5.11.2 COMPLEMENTARY TECHNOLOGIES
    • 5.11.2.1 Single-use technology
  • 5.11.3 ADJACENT TECHNOLOGIES
    • 5.11.3.1 Chromatography
• 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.13 TRADE ANALYSIS
  • 5.13.1 EXPORT SCENARIO (HS CODE 8421)
  • 5.13.2 IMPORT SCENARIO (HS CODE 8421)
• 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.15 PRICING ANALYSIS
  • 5.15.1 AVERAGE SELLING PRICE TREND, BY REGION, 2021-2023
  • 5.15.2 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021-2023
  • 5.15.3 AVERAGE SELLING PRICE TREND, BY END USER, 2021-2023
• 5.16 INVESTMENT AND FUNDING SCENARIO
• 5.17 PATENT ANALYSIS
  • 5.17.1 INTRODUCTION
  • 5.17.2 LEGAL STATUS OF PATENTS
  • 5.17.3 JURISDICTION ANALYSIS

6 MEDICAL FILTRATION MARKET, BY MATERIAL

• 6.1 INTRODUCTION
• 6.2 POLYSULFONE & POLYETHERSULFONE
  • 6.2.1 EXCELLENT MECHANICAL STRENGTH, THERMAL STABILITY, AND CHEMICAL RESISTANCE TO BOOST MARKET
• 6.3 POLYVINYLIDENE FLUORIDE
  • 6.3.1 EXCEPTIONAL CHEMICAL RESISTANCE, THERMAL STABILITY, AND MECHANICAL STRENGTH TO DRIVE MARKET
• 6.4 POLYTETRAFLUOROETHYLENE
  • 6.4.1 SUPERIOR FILTRATION PERFORMANCE IN CRITICAL MEDICAL APPLICATIONS TO PROPEL DEMAND
• 6.5 POLYPROPYLENE
  • 6.5.1 EXCELLENT CHEMICAL RESISTANCE, DURABILITY, AND COST-EFFECTIVENESS TO DRIVE DEMAND
• 6.6 OTHER MATERIALS

7 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 ULTRAFILTRATION
  • 7.2.1 INCREASING PREVALENCE OF CHRONIC KIDNEY DISEASE AND RISING DEMAND FOR DIALYSIS TREATMENTS TO BOOST MARKET
• 7.3 MICROFILTRATION
  • 7.3.1 GROWING USAGE IN STERILIZATION, WATER PURIFICATION, AND BIOPHARMACEUTICAL MANUFACTURING TO DRIVE DEMAND
• 7.4 NANOFILTRATION
  • 7.4.1 LOW ENERGY CONSUMPTION AND HIGH FILTRATION EFFICIENCY TO SUPPORT MARKET GROWTH
• 7.5 REVERSE OSMOSIS
  • 7.5.1 CRUCIAL ROLE IN ENSURING SAFETY OF WATER IN MEDICAL PROCEDURES TO BOOST MARKET
• 7.6 GAS FILTRATION
  • 7.6.1 DELIVERY OF HIGH-QUALITY FILTERED AIR TO FUEL GROWTH
• 7.7 OTHER PROCESS TECHNOLOGIES

8 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS

• 8.1 INTRODUCTION
• 8.2 SYSTEMS (RTU UNITS)
  • 8.2.1 CONVENIENCE, TIME-SAVING BENEFITS, AND ABILITY TO ENSURE CONSISTENT FILTRATION PERFORMANCE TO BOOST MARKET
• 8.3 FILTRATION MODULES (CONSUMABLES)
  • 8.3.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND FOR FILTRATION MODULES IN HEALTHCARE
• 8.4 OTHER DESIGNS/PROCESSES

9 MEDICAL FILTRATION MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 REQUIREMENT OF HIGH-PURITY WATER FOR WOUND CARE, SURGICAL PROCEDURES, STERILIZATION, AND DIALYSIS TO DRIVE MARKET
• 9.3 DIAGNOSTIC CENTERS
  • 9.3.1 DEMAND FOR HIGH-PURITY WATER, FLUIDS, AND AIR TO ENSURE RELIABLE DIAGNOSTICS TO DRIVE GROWTH
• 9.4 RESEARCH INSTITUTES
  • 9.4.1 INCREASE IN BIOLOGICAL STUDIES, AND MEDICAL RESEARCH TO BOOST MARKET
• 9.5 OTHER END USERS

10 MEDICAL FILTRATION MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 DIALYSIS
  • 10.2.1 ACCURACY AND OPERATIONAL FILTRATION EFFICIENCY IN BLOOD PURIFICATION TO BOOST GROWTH
• 10.3 DRUG DELIVERY
  • 10.3.1 PROVISION OF OPTIMAL CONDITIONS THROUGH CONSISTENT FLOW RATES AND MINIMUM PRESSURE DROPS TO FUEL MARKET GROWTH
• 10.4 IV INFUSION & STERILE FILTRATION
  • 10.4.1 HIGH LEVEL OF PRECISION IN CONTAMINANT REMOVAL WHILE PRESERVING FLUID INTEGRITY TO DRIVE GROWTH
• 10.5 ENDOSCOPY
  • 10.5.1 ENHANCEMENT OF SAFETY AND PERFORMANCE WITH ADVANCED FILTRATION TO BOOST MARKET
• 10.6 STERILE PROCESSING
  • 10.6.1 GROWING DEMAND FOR SURGICAL INSTRUMENTS, ENDOSCOPES, AND REUSABLE MEDICAL DEVICES TO PROPEL MARKET
• 10.7 BIO-ARTIFICIAL PROCESSES
  • 10.7.1 VITAL ROLE OF SOPHISTICATED FILTRATION SYSTEMS IN DEVELOPMENT AND FUNCTIONALITY OF BIO-ARTIFICIAL ORGANS TO BOOST MARKET
• 10.8 OTHER APPLICATIONS

11 MEDICAL FILTRATION MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 ASIA PACIFIC
  • 11.2.1 CHINA
    • 11.2.1.1 Strong economic growth and expanding healthcare sector to drive market
  • 11.2.2 JAPAN
    • 11.2.2.1 Growing aging population to propel market
  • 11.2.3 INDIA
    • 11.2.3.1 Increasing investments in healthcare sector to drive market
  • 11.2.4 SOUTH KOREA
    • 11.2.4.1 Rising demand for high-quality medical filtration solutions to drive market
  • 11.2.5 REST OF ASIA PACIFIC
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Economic strength, increasing healthcare expenditure, and rapidly aging population to drive market
  • 11.3.2 UK
    • 11.3.2.1 Rising geriatric population to support market growth
  • 11.3.3 FRANCE
    • 11.3.3.1 Aging population and enhancement of healthcare system to propel market
  • 11.3.4 ITALY
    • 11.3.4.1 Growing aging population to increase demand
  • 11.3.5 SPAIN
    • 11.3.5.1 Rising demand for advanced medical solutions to propel market
  • 11.3.6 REST OF EUROPE
• 11.4 NORTH AMERICA
  • 11.4.1 US
    • 11.4.1.1 Stringent regulatory guidelines and increasing healthcare spending to boost market
  • 11.4.2 CANADA
    • 11.4.2.1 Growing aging population and significant government investments in healthcare infrastructure to drive market growth
  • 11.4.3 MEXICO
    • 11.4.3.1 Government initiatives and growth of healthcare sector to drive market
• 11.5 MIDDLE EAST & AFRICA
  • 11.5.1 GCC COUNTRIES
    • 11.5.1.1 Saudi Arabia
      • 11.5.1.1.1 Economic growth, increasing government investments, and rising healthcare expenditures to drive market
    • 11.5.1.2 Rest of GCC Countries
  • 11.5.2 SOUTH AFRICA
    • 11.5.2.1 Outbreaks of contagious diseases to drive demand
  • 11.5.3 REST OF MIDDLE EAST & AFRICA
• 11.6 SOUTH AMERICA
  • 11.6.1 BRAZIL
    • 11.6.1.1 Rising healthcare investments and expanding medical infrastructure to propel growth
  • 11.6.2 ARGENTINA
    • 11.6.2.1 Increasing healthcare expenditure and enhancement of medical infrastructure to drive market
  • 11.6.3 REST OF SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 12.3 REVENUE ANALYSIS, 2021-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 PRODUCT COMPARISON
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.7.5.1 Region footprint
    • 12.7.5.2 Material footprint
    • 12.7.5.3 Process technology footprint
    • 12.7.5.4 Design/Process footprint
    • 12.7.5.5 Application footprint
    • 12.7.5.6 End user footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of key startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS
  • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES - MEDICAL FILTRATION EQUIPMENT PROVIDERS

• 13.1 KEY PLAYERS
  • 13.1.1 MERCK KGAA
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 3M (SOLVENTUM)
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Other developments
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 DANAHER
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Deals
      • 13.1.3.3.2 Other developments
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 SARTORIUS AG
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 ASAHI KASEI CORPORATION
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 MnM view
      • 13.1.5.3.1 Right to win
      • 13.1.5.3.2 Strategic choices
      • 13.1.5.3.3 Weaknesses and competitive threats
  • 13.1.6 BAXTER
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
    • 13.1.6.4 MnM view
      • 13.1.6.4.1 Right to win
      • 13.1.6.4.2 Strategic choices
      • 13.1.6.4.3 Weaknesses and competitive threats
  • 13.1.7 THERMO FISHER SCIENTIFIC INC.
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 MnM view
  • 13.1.8 VEOLIA
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
    • 13.1.8.4 MnM view
      • 13.1.8.4.1 Right to win
      • 13.1.8.4.2 Strategic choices
      • 13.1.8.4.3 Weaknesses and competitive threats
  • 13.1.9 DONALDSON COMPANY, INC.
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Expansions
    • 13.1.9.4 MnM view
  • 13.1.10 PARKER HANNIFIN CORP
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 MnM view
  • 13.1.11 ENTEGRIS
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Solutions/Services offered
    • 13.1.11.3 MnM view
  • 13.1.12 MANN+HUMMEL
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Solutions/Services offered
    • 13.1.12.3 MnM view
• 13.2 OTHER PLAYERS
  • 13.2.1 CORNING INCORPORATED
  • 13.2.2 CRITICAL PROCESS FILTRATION, INC.
  • 13.2.3 COBETTER
  • 13.2.4 GRAVER TECHNOLOGIES
  • 13.2.5 ERTELALSOP
  • 13.2.6 KASAG SWISS AG
  • 13.2.7 FILTROX AG
  • 13.2.8 MEMBRANE SOLUTIONS
  • 13.2.9 COLE-PARMER INSTRUMENT COMPANY, LLC
  • 13.2.10 MEISSNER FILTRATION PRODUCTS, INC.
  • 13.2.11 MEDICAL FILTRATION SOLUTIONS LTD.
  • 13.2.12 SEFAR AG
  • 13.2.13 WALKER FILTRATION
  • 13.2.14 SAINT-GOBAIN

14 COMPANY PROFILES - AUTOMATED ENDOSCOPE REPROCESSOR PROVIDERS

• 14.1 KEY PLAYERS
  • 14.1.1 STERIS
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products/Solutions/Services offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Deals
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses and competitive threats
  • 14.1.2 FORTIVE
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products/Solutions/Services offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Deals
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses and competitive threats
  • 14.1.3 OLYMPUS CORPORATION
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products/Solutions/Services offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product launches
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses and competitive threats
  • 14.1.4 ECOLAB
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products/Solutions/Services offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Product launches
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Right to win
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses and competitive threats
  • 14.1.5 GETINGE
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products/Solutions/Services offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Expansions
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Right to win
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses and competitive threats
  • 14.1.6 STEELCOBELIMED (METALL ZUG GROUP)
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products/Solutions/Services offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Deals
    • 14.1.6.4 MnM view
  • 14.1.7 ENDO-TECHNIK W. GRIESAT (CREO)
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products/Solutions/Services offered
    • 14.1.7.3 MnM view
  • 14.1.8 WASSENBURG MEDICAL B.V. (HOYA CORPORATION)
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products/Solutions/Services offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Deals

15 COMPANY PROFILES - DIALYSIS EQUIPMENT PROVIDERS

• 15.1 KEY PLAYERS
  • 15.1.1 FRESENIUS MEDICAL CARE AG
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products/Solutions/Services offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Product launches
      • 15.1.1.3.2 Deals
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Right to win
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses and competitive threats
  • 15.1.2 BAXTER
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products/Solutions/Services offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Deals
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Right to win
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses and competitive threats
  • 15.1.3 DAVITA INC.
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products/Solutions/Services offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Deals
      • 15.1.3.3.2 Expansions
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Right to win
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses and competitive threats
  • 15.1.4 NIKKISO CO., LTD.
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products/Solutions/Services offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Deals
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Right to win
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses and competitive threats
  • 15.1.5 B. BRAUN SE
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products/Solutions/Services offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Product launches
      • 15.1.5.3.2 Expansions
    • 15.1.5.4 MnM view
      • 15.1.5.4.1 Right to win
      • 15.1.5.4.2 Strategic choices
      • 15.1.5.4.3 Weaknesses and competitive threats
  • 15.1.6 NIPRO
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products/Solutions/Services offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Product launches
  • 15.1.7 TORAY MEDICAL CO., LTD.
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products/Solutions/Services offered
  • 15.1.8 MEDIONICS
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products/Solutions/Services offered

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS

List of Tables

• TABLE 1 CAPITAL HEALTHCARE EXPENDITURE, 2020-2023 (USD MILLION)
• TABLE 2 HEALTHCARE SPENDING, 2023 (USD MILLION)
• TABLE 3 MEDICAL FILTRATION MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
• TABLE 5 KEY BUYING CRITERIA FOR TOP THREE END USERS
• TABLE 6 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019-2023
• TABLE 7 ANNUAL GDP PERCENTAGE CHANGE AND PROJECTIONS FOR KEY COUNTRIES, 2024-2029
• TABLE 8 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019-2022
• TABLE 9 MEDICAL FILTRATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM
• TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 13 EXPORT SCENARIO FOR HS CODE 8421-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 14 IMPORT SCENARIO FOR HS CODE 8421-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 15 MEDICAL FILTRATION MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
• TABLE 16 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
• TABLE 17 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
• TABLE 18 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
• TABLE 19 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 20 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
• TABLE 21 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
• TABLE 22 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
• TABLE 23 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 24 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
• TABLE 25 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
• TABLE 26 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
• TABLE 27 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
• TABLE 28 MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
• TABLE 29 MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
• TABLE 30 MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
• TABLE 31 MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
• TABLE 32 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 33 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 34 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 35 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 36 MEDICAL FILTRATION MARKET, BY REGION, 2021-2023 (UNIT)
• TABLE 37 MEDICAL FILTRATION MARKET, BY REGION, 2024-2030 (UNIT)
• TABLE 38 MEDICAL FILTRATION MARKET, BY REGION, 2021-2023 (USD MILLION)
• TABLE 39 MEDICAL FILTRATION MARKET, BY REGION, 2024-2030 (USD MILLION)
• TABLE 40 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
• TABLE 41 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
• TABLE 42 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
• TABLE 43 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 44 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
• TABLE 45 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
• TABLE 46 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
• TABLE 47 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 48 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
• TABLE 49 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
• TABLE 50 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
• TABLE 51 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 52 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
• TABLE 53 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
• TABLE 54 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
• TABLE 55 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
• TABLE 56 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
• TABLE 57 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
• TABLE 58 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
• TABLE 59 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
• TABLE 60 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 61 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 62 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 63 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 64 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 65 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 66 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 67 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 68 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 69 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 70 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 71 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 72 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 73 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 74 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 75 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 76 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 77 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 78 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 79 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 80 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 81 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 82 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 83 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 84 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
• TABLE 85 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
• TABLE 86 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
• TABLE 87 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 88 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
• TABLE 89 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
• TABLE 90 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
• TABLE 91 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 92 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
• TABLE 93 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
• TABLE 94 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
• TABLE 95 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 96 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
• TABLE 97 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
• TABLE 98 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
• TABLE 99 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
• TABLE 100 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
• TABLE 101 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
• TABLE 102 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
• TABLE 103 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
• TABLE 104 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 105 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 106 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 107 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 108 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 109 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 110 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 111 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 112 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 113 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 114 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 115 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 116 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 117 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 118 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 119 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 120 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 121 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 122 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 123 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 124 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 125 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 126 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 127 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 128 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 129 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 130 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 131 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 132 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
• TABLE 133 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
• TABLE 134 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
• TABLE 135 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 136 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
• TABLE 137 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
• TABLE 138 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
• TABLE 139 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 140 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
• TABLE 141 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
• TABLE 142 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
• TABLE 143 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 144 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
• TABLE 145 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
• TABLE 146 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
• TABLE 147 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
• TABLE 148 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
• TABLE 149 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
• TABLE 150 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
• TABLE 151 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
• TABLE 152 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 153 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 154 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 155 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 156 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 157 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 158 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 159 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 160 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 161 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 162 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 163 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 164 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 165 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 166 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 167 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 168 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
• TABLE 169 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
• TABLE 170 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
• TABLE 171 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 172 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
• TABLE 173 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
• TABLE 174 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
• TABLE 175 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 176 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
• TABLE 177 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
• TABLE 178 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
• TABLE 179 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 180 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
• TABLE 181 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
• TABLE 182 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
• TABLE 183 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
• TABLE 184 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
• TABLE 185 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
• TABLE 186 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
• TABLE 187 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
• TABLE 188 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 189 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 190 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 191 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 192 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 193 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 194 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 195 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 196 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 197 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 198 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 199 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 200 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 201 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 202 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 203 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 204 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 205 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 206 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 207 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 208 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
• TABLE 209 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
• TABLE 210 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
• TABLE 211 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 212 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
• TABLE 213 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
• TABLE 214 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
• TABLE 215 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
• TABLE 216 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
• TABLE 217 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
• TABLE 218 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
• TABLE 219 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 220 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
• TABLE 221 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
• TABLE 222 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
• TABLE 223 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
• TABLE 224 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
• TABLE 225 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
• TABLE 226 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
• TABLE 227 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
• TABLE 228 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 229 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 230 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 231 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 232 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 233 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 234 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 235 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 236 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 237 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 238 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 239 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 240 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
• TABLE 241 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
• TABLE 242 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
• TABLE 243 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 244 MEDICAL FILTRATION MARKET: DEGREE OF COMPETITION
• TABLE 245 MEDICAL FILTRATION MARKET: REGION FOOTPRINT
• TABLE 246 MEDICAL FILTRATION MARKET: MATERIAL FOOTPRINT
• TABLE 247 MEDICAL FILTRATION MARKET: PROCESS TECHNOLOGY FOOTPRINT
• TABLE 248 MEDICAL FILTRATION MARKET: DESIGN/PROCESS FOOTPRINT
• TABLE 249 MEDICAL FILTRATION MARKET: APPLICATION FOOTPRINT
• TABLE 250 MEDICAL FILTRATION MARKET: END USER FOOTPRINT
• TABLE 251 MEDICAL FILTRATION MARKET: KEY STARTUPS/SMES
• TABLE 252 MEDICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
• TABLE 253 MEDICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
• TABLE 254 MEDICAL FILTRATION MARKET: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 255 MEDICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019-JANUARY 2025
• TABLE 256 MEDICAL FILTRATION MARKET: OTHER DEVELOPMENTS, JANUARY 2019-JANUARY 2025
• TABLE 257 MERCK KGAA: COMPANY OVERVIEW
• TABLE 258 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 259 MERCK KGAA: EXPANSIONS, JANUARY 2019-JANUARY 2025
• TABLE 260 3M (SOLVENTUM): COMPANY OVERVIEW
• TABLE 261 3M (SOLVENTUM): PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 262 3M (SOLVENTUM): OTHER DEVELOPMENTS, JANUARY 2019-JANUARY 2025
• TABLE 263 DANAHER: COMPANY OVERVIEW
• TABLE 264 DANAHER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 265 DANAHER: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 266 DANAHER: OTHERS, JANUARY 2019-JANUARY 2025
• TABLE 267 SARTORIUS AG: COMPANY OVERVIEW
• TABLE 268 SARTORIUS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 269 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
• TABLE 270 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
• TABLE 271 ASAHI KASEI CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 272 BAXTER: COMPANY OVERVIEW
• TABLE 273 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 274 BAXTER: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 275 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• TABLE 276 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 277 VEOLIA: COMPANY OVERVIEW
• TABLE 278 VEOLIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 279 VEOLIA: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
• TABLE 280 DONALDSON COMPANY, INC.: COMPANY OVERVIEW
• TABLE 281 DONALDSON COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 282 DONALDSON COMPANY, INC.: EXPANSIONS, JANUARY 2019-JANUARY 2025
• TABLE 283 PARKER HANNIFIN CORP: COMPANY OVERVIEW
• TABLE 284 PARKER HANNIFIN CORP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 285 ENTEGRIS: COMPANY OVERVIEW
• TABLE 286 ENTEGRIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 287 MANN+HUMMEL: COMPANY OVERVIEW
• TABLE 288 MANN+HUMMEL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 289 CORNING INCORPORATED: COMPANY OVERVIEW
• TABLE 290 CRITICAL PROCESS FILTRATION, INC.: COMPANY OVERVIEW
• TABLE 291 COBETTER: COMPANY OVERVIEW
• TABLE 292 GRAVER TECHNOLOGIES: COMPANY OVERVIEW
• TABLE 293 ERTELALSOP: COMPANY OVERVIEW
• TABLE 294 KASAG SWISS AG: COMPANY OVERVIEW
• TABLE 295 FILTROX AG: COMPANY OVERVIEW
• TABLE 296 MEMBRANE SOLUTIONS: COMPANY OVERVIEW
• TABLE 297 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW
• TABLE 298 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
• TABLE 299 MEDICAL FILTRATION SOLUTIONS LTD.: COMPANY OVERVIEW
• TABLE 300 SEFAR AG: COMPANY OVERVIEW
• TABLE 301 WALKER FILTRATION: COMPANY OVERVIEW
• TABLE 302 SAINT-GOBAIN: COMPANY OVERVIEW
• TABLE 303 STERIS: COMPANY OVERVIEW
• TABLE 304 STERIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 305 STERIS: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 306 FORTIVE: COMPANY OVERVIEW
• TABLE 307 FORTIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 308 FORTIVE: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 309 OLYMPUS CORPORATION: COMPANY OVERVIEW
• TABLE 310 OLYMPUS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 311 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
• TABLE 312 ECOLAB: COMPANY OVERVIEW
• TABLE 313 ECOLAB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 314 ECOLAB: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
• TABLE 315 GETINGE: COMPANY OVERVIEW
• TABLE 316 GETINGE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 317 GETINGE: EXPANSIONS, JANUARY 2019-JANUARY 2025
• TABLE 318 STEELCOBELIMED (METALL ZUG GROUP): COMPANY OVERVIEW
• TABLE 319 STEELCOBELIMED (METALL ZUG GROUP): PRODUCTS/SOLUTIONS/ SERVICES OFFERED
• TABLE 320 STEELCOBELIMED (METALL ZUG GROUP): DEALS, JANUARY 2019-JANUARY 2025
• TABLE 321 ENDO-TECHNIK W. GRIESAT (CREO): COMPANY OVERVIEW
• TABLE 322 ENDO-TECHNIK W. GRIESAT (CREO): PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 323 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): COMPANY OVERVIEW
• TABLE 324 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 325 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): DEALS, JANUARY 2019-JANUARY 2025
• TABLE 326 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
• TABLE 327 FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 328 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
• TABLE 329 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 330 BAXTER: COMPANY OVERVIEW
• TABLE 331 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 332 BAXTER: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 333 DAVITA INC.: COMPANY OVERVIEW
• TABLE 334 DAVITA INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 335 DAVITA INC.: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 336 DAVITA INC.: EXPANSIONS, JANUARY 2019-JANUARY 2025
• TABLE 337 NIKKISO CO., LTD.: COMPANY OVERVIEW
• TABLE 338 NIKKISO CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 339 NIKKISO CO., LTD.: DEALS, JANUARY 2019-JANUARY 2025
• TABLE 340 B. BRAUN SE: COMPANY OVERVIEW
• TABLE 341 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 342 B. BRAUN SE: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
• TABLE 343 B. BRAUN SE: EXPANSIONS, JANUARY 2019-JANUARY 2025
• TABLE 344 NIPRO: COMPANY OVERVIEW
• TABLE 345 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 346 NIPRO: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
• TABLE 347 TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW
• TABLE 348 TORAY MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 349 MEDIONICS: COMPANY OVERVIEW
• TABLE 350 MEDIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED

List of Figures

• FIGURE 1 MEDICAL FILTRATION MARKET AND REGIONAL SCOPE
• FIGURE 2 MEDICAL FILTRATION MARKET: RESEARCH DESIGN
• FIGURE 3 MEDICAL FILTRATION MARKET: BOTTOM-UP APPROACH
• FIGURE 4 MEDICAL FILTRATION MARKET: TOP-DOWN APPROACH
• FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL FILTRATION MARKET (TOP-DOWN APPROACH)
• FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS
• FIGURE 7 MEDICAL FILTRATION MARKET: DATA TRIANGULATION
• FIGURE 8 POLYSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 9 DIALYSIS APPLICATION TO LEAD MARKET DURING FORECAST PERIOD
• FIGURE 10 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
• FIGURE 12 GROWING FOCUS ON INFECTION CONTROL IN HEALTHCARE SECTOR TO DRIVE MARKET
• FIGURE 13 POLYSULFONE & POLYETHERSULFONE SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 14 IV INFUSION & STERILE FILTRATION SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 15 HOSPITALS TO BE LARGEST END USER SEGMENT DURING FORECAST PERIOD
• FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL FILTRATION MARKET
• FIGURE 18 MEDICAL FILTRATION MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
• FIGURE 20 KEY BUYING CRITERIA FOR TOP THREE END USERS
• FIGURE 21 MEDICAL FILTRATION MARKET: VALUE CHAIN ANALYSIS
• FIGURE 22 MEDICAL FILTRATION MARKET: ECOSYSTEM
• FIGURE 23 MEDICAL FILTRATION MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• FIGURE 24 EXPORT DATA FOR HS CODE 8421-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
• FIGURE 25 IMPORT DATA FOR HS CODE 8421-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
• FIGURE 26 AVERAGE SELLING PRICE TREND, BY REGION, 2021-2023 (USD/UNIT)
• FIGURE 27 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021-2023 (USD/UNIT)
• FIGURE 28 AVERAGE SELLING PRICE TREND, BY END USER, 2021-2023 (USD/UNIT)
• FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2020-2024 (USD MILLION)
• FIGURE 30 PATENTS APPLIED AND GRANTED, 2014-2024
• FIGURE 31 LEGAL STATUS OF PATENTS, 2014-2024
• FIGURE 32 TOP JURISDICTIONS
• FIGURE 33 POLYETHERSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 34 MICROFILTRATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 35 FILTRATION MODULES (CONSUMABLES) SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 36 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 37 DIALYSIS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 38 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 39 ASIA PACIFIC: MEDICAL FILTRATION MARKET SNAPSHOT
• FIGURE 40 EUROPE: MEDICAL FILTRATION MARKET SNAPSHOT
• FIGURE 41 NORTH AMERICA: MEDICAL FILTRATION MARKET SNAPSHOT
• FIGURE 42 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL FILTRATION MARKET BETWEEN 2019 AND 2024
• FIGURE 43 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN MEDICAL FILTRATION MARKET, 2021-2023
• FIGURE 44 MARKET SHARE OF KEY COMPANIES IN MEDICAL FILTRATION MARKET, 2023
• FIGURE 45 VALUATION OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023
• FIGURE 46 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023
• FIGURE 47 MEDICAL FILTRATION MARKET: PRODUCT COMPARISON ANALYSIS
• FIGURE 48 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2023
• FIGURE 49 MEDICAL FILTRATION MARKET: OVERALL COMPANY FOOTPRINT
• FIGURE 50 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023
• FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT
• FIGURE 52 3M (SOLVENTUM): COMPANY SNAPSHOT
• FIGURE 53 DANAHER: COMPANY SNAPSHOT
• FIGURE 54 SARTORIUS AG: COMPANY SNAPSHOT
• FIGURE 55 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
• FIGURE 56 BAXTER: COMPANY SNAPSHOT
• FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
• FIGURE 58 VEOLIA: COMPANY SNAPSHOT
• FIGURE 59 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT
• FIGURE 60 PARKER HANNIFIN CORP: COMPANY SNAPSHOT
• FIGURE 61 ENTEGRIS: COMPANY SNAPSHOT
• FIGURE 62 MANN+HUMMEL: COMPANY SNAPSHOT
• FIGURE 63 STERIS: COMPANY SNAPSHOT
• FIGURE 64 FORTIVE: COMPANY SNAPSHOT
• FIGURE 65 OLYMPUS CORPORATION: COMPANY SNAPSHOT
• FIGURE 66 ECOLAB: COMPANY SNAPSHOT
• FIGURE 67 GETINGE: COMPANY SNAPSHOT
• FIGURE 68 STEELCOBELIMED (METALL ZUG GROUP): COMPANY SNAPSHOT
• FIGURE 69 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT
• FIGURE 70 BAXTER: COMPANY SNAPSHOT
• FIGURE 71 DAVITA INC.: COMPANY SNAPSHOT
• FIGURE 72 NIKKISO CO., LTD.: COMPANY SNAPSHOT
• FIGURE 73 B. BRAUN SE: COMPANY SNAPSHOT
• FIGURE 74 NIPRO: COMPANY SNAPSHOT
• FIGURE 75 TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT